Market Snapshot

BSE Sensex: 76664.21 -1.29%
BSE 500: 35349.66 -1.06%
BSE 200: 11074.32 -1.05%
BSE 100: 25300.66 -1.08%
BSE BANKEX: 63188.31 -0.44%
BSE IT: 27648.74 -5.13%
Nifty 50: 23897.95 -1.14%
Nifty 500: 22570.05 -1.06%
Nifty 200: 13656.85 -1.05%
Nifty 100: 24827.3 -1.07%
Nifty Midcap 100: 59374.8 -0.96%
Nifty Small 100: 17567.2 -0.87%
Nifty IT: 28530.6 -5.29%
Nifty PSU Bank: 8811.2 -0.15%

News:

IDFC FIRST Bank Q4 PAT rises 4...
Supreme Petrochem Q4 PAT jumps...
RBL Bank Q4 PAT spurts 234% Yo...
Lodha Developers Q4 PAT jumps ...
Axis Bank Q4 PAT marginally sl...

Glaxosmithkline Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

24 Apr 2026 | 03:59 PM

2,473.05

-18.35 (-0.74%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-11.8%

Return (1Y)

Underperformed BSE Healthcare by 15.37%
More Volatile

1.86%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.05%
Not so consistent

4/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

3,516

2,218

News & Announcements

GlaxoSmithKline Pharmaceuticals to announce Quarterly Result
5 days ago

GlaxoSmithKline Pharmaceuticals to announce Quarterly Result

22 - Apr - 2026 12:00 | 5 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 May 2026.
Glaxosmithkline appoints Vinay Subramanian as Commercial Head - Oncology
6 days ago

Glaxosmithkline appoints Vinay Subramanian as Commercial Head - Oncology

21 - Apr - 2026 12:00 | 6 days ago

Glaxosmithkline Pharmaceuticals announced that Vinay Subramanian, Commercial Head - Oncology would be part of leadership team effective 20 April 2026 based out of Mumbai, and he would be part of senior Management Personnel of the Company effective the said date.
Vinay brings with him over 24 years of experience in the Pharmaceuticals, Life Science. Healthcare Devices, and Medical Technology sectors. Prior to joining GSK. he served as the India Enabling leader - Enterprise & Neighboring Countries at Roche Products India Pvt ltd. where he was responsible for the immunotherapy portfolio and was part of their leadership team.
Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
77 days ago

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

09 - Feb - 2026 12:00 | 77 days ago

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 1041.26 949.42 10

OPM % 35.66 30.75 -

PBDT 402.27 326.90 23

PBT 381.95 308.10 24

NP 295.62 229.88 29

Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals to table results
110 days ago

GlaxoSmithKline Pharmaceuticals to table results

07 - Jan - 2026 12:00 | 110 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 February 2026.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Glaxosmithkline Pharma Ltd has decreased by -8.47% since past 1 Year
GovT shareholding in Glaxosmithkline Pharma Ltd has decreased by -97.3% since past 1 Year
Glaxosmithkline Pharma Ltd has the 3rd highest P/Bratio according to FY202503 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

General Notifications

My Notifications

Research Notifications

Glaxosmithkline Pharmaceuticals Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

2,473.05 -18.35 (-0.74%)

News & Announcements

Price vs Volume

Stock Trivia

Glaxosmithkline Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

2,473.05

-18.35 (-0.74%)